[Trasylol in hyperfibrinolytic conditions].
D007611:Aprotinin / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D005342:Fibrinolysis; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control
D007611:Aprotinin
Trasylol bie hyperfibrinolytischen Zuständen.